New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.
- DOI
- 10.1007/s00280-025-04749-w
- Published
- 2025-03-13
- Container
- Cancer Chemother Pharmacol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-025-04749-w,
title = {New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.},
author = {Heldrup J and Bleyer A and Ramsey L and Schaff L and Bernhardt B and Schwartz S and Chatelut E and Hwang M and Ten C and Guscott M and Howard S.},
year = {2025},
journal = {Cancer Chemother Pharmacol},
doi = {10.1007/s00280-025-04749-w},
url = {https://doi.org/10.1007/s00280-025-04749-w}
}RIS
TY - JOUR TI - New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid. AU - Heldrup J AU - Bleyer A AU - Ramsey L AU - Schaff L AU - Bernhardt B AU - Schwartz S AU - Chatelut E AU - Hwang M AU - Ten C AU - Guscott M AU - Howard S. PY - 2025 JO - Cancer Chemother Pharmacol DO - 10.1007/s00280-025-04749-w UR - https://doi.org/10.1007/s00280-025-04749-w ER -
APA
J, H., A, B., L, R., L, S., B, B., S, S., E, C., M, H., C, T., M, G., & S., H. (2025). New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-025-04749-w
Source records
- europe-pmc · retrieved 2026-09-25T06:30:36.576Z